In a controversial move, a vaccine advisory panel recommends removing thimerosal from flu vaccines despite studies showing its benefits. Discover the implications for public health and vaccine safety.
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
The U.S. government has canceled a crucial $770 million contract with Moderna for an avian flu vaccine, risking public health as pandemics prove to be a costly threat. Experts warn of the implications of prioritizing military spending over health security.
In a surprising move, the Department of Health and Human Services has withdrawn millions in funding for Moderna's bird flu vaccine development, raising concerns about the nation's pandemic preparedness amid ongoing tensions over vaccine safety.
Vaccine experts are divided over the Trump administration's Generation Gold Standard project aimed at creating a universal flu vaccine. While some praise the initiative, others question its outdated methods and hefty price tag.
Moderna's combined Covid and flu vaccine has outperformed traditional shots in a recent phase 3 trial, generating higher antibody levels and showing promise for dual protection against both viruses.
The announcement of a $500 million NIH project to develop a vaccine platform using outdated technology has divided experts, sparking concerns about the future of pandemic preparedness and funding priorities.
The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
In an unprecedented move, U.S. Senators express deep concerns over the FDA's cancellation of a critical VRBPAC meeting, risking vaccine availability during the worst flu season in 15 years. The senators demand accountability and clarity from nominee Dr. Marty Makary.
The recent cancellation of a key FDA meeting on flu vaccine strains has raised alarms among health experts, who fear it could impact vaccine quality and availability. With flu season approaching, is the U.S. prepared to protect its citizens?
